Literature DB >> 17680990

NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via Ras/ERK1/2 pathway.

A Scorziello1, M Santillo, A Adornetto, C Dell'aversano, R Sirabella, S Damiano, L M T Canzoniero, G F Di Renzo, L Annunziato.   

Abstract

To identify the transductional mechanisms responsible for the neuroprotective effect of nitric oxide (NO) during ischemic preconditioning (IPC), we investigated the effects of this gaseous mediator on mitochondrial Mn-superoxide dismutase (Mn-SOD) expression and activity. In addition, the possible involvement of Ras/extracellular-regulated kinase (ERK) ERK1/2 pathway in preserving cortical neurons exposed to oxygen and glucose deprivation (OGD) followed by reoxygenation was also examined. Ischemic preconditioning was obtained by exposing neurons to a 30-min sublethal OGD (95% N(2) and 5% CO(2)). Then, after a 24-h interval, neurons were exposed to 3 h of OGD followed by 24 h of reoxygenation (OGD/Rx). Our results revealed that IPC reduced cytochrome c (cyt c) release into the cytosol, improved mitochondrial function, and decreased free radical production. Moreover, it induced an increase in nNOS expression and NO production and promoted ERK1/2 activation. These effects were paralleled by an increase in Mn-SOD expression and activity that persisted throughout the following OGD phase. When the neurons were treated with L-NAME, a well known NOS inhibitor, the increase in Mn-SOD expression occurring during IPC was reduced and, as a result, IPC-induced neuroprotection was prevented. Similarly, when ERK1/2 was inhibited by its selective inhibitor PD98059, the increase in Mn-SOD expression observed during IPC was almost completely abolished. As a result, its neuroprotective effect on cellular survival was thwarted. The present findings indicate that during IPC the increase in Mn-SOD expression and activity are paralleled by NO production. This suggests that NO neuroprotective role occurs through the stimulation of Mn-SOD expression and activity. In particular, NO via Ras activation stimulates downstream ERK1/2 cascade. This pathway, in turn, post-transcriptionally activates Mn-SOD expression and activity, thus promoting neuroprotection during preconditioning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680990     DOI: 10.1111/j.1471-4159.2007.04845.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

2.  MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits.

Authors:  Antonio Vinciguerra; Luigi Formisano; Pierpaolo Cerullo; Natascia Guida; Ornella Cuomo; Alba Esposito; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

3.  Endoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection.

Authors:  M J Sisalli; A Secondo; A Esposito; V Valsecchi; C Savoia; G F Di Renzo; L Annunziato; A Scorziello
Journal:  Cell Death Differ       Date:  2014-03-14       Impact factor: 15.828

4.  Preconditioning with the BKCa channel activator NS-1619 prevents ischemia-reperfusion-induced inflammation and mucosal barrier dysfunction: roles for ROS and heme oxygenase-1.

Authors:  Hongyan Dai; Meifang Wang; Parag N Patel; Theodore Kalogeris; Yajun Liu; William Durante; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

5.  Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning.

Authors:  Jacquelynn E Brown; Stephanie L H Zeiger; Jane C Hettinger; Joshua D Brooks; Benjamin Holt; Jason D Morrow; Erik S Musiek; Ginger Milne; Bethann McLaughlin
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

Review 6.  Mitochondria: the missing link between preconditioning and neuroprotection.

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS.

Authors:  Amy Bishop; Renea Gooch; Asuka Eguchi; Stephanie Jeffrey; Lorraine Smallwood; James Anderson; Alvaro G Estevez
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

8.  The immediate effect of nitric oxide on the rabbit bladder after ovariectomy.

Authors:  Yung-Shun Juan; Anita Mannikarottu; Catherine Schuler; Wei-Yu Lin; Chun-Hsiung Huang; Robert M Levin
Journal:  Nitric Oxide       Date:  2008-06-21       Impact factor: 4.427

9.  Involvement of erythropoietin in retinal ischemic preconditioning.

Authors:  John C Dreixler; Sarah Hagevik; Jonathan W Hemmert; Afzhal R Shaikh; Daniel M Rosenbaum; Steven Roth
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

10.  Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state.

Authors:  Chiara Laezza; Laura Fiorentino; Simona Pisanti; Patrizia Gazzerro; Michele Caraglia; Giuseppe Portella; Mario Vitale; Maurizio Bifulco
Journal:  J Mol Med (Berl)       Date:  2008-09-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.